Core Nursing Explanation
Key Concept Analysis: This question tests the critical nursing intervention for preventing the most serious complication of
Kawasaki disease (KD) – coronary artery thrombosis leading to myocardial infarction (MI). The pathophysiology involves a systemic
vasculitis that particularly affects medium-sized arteries, especially the coronary arteries. The inflammation can damage the vessel wall, leading to aneurysm formation. During the acute phase, the endothelium is inflamed and platelets are highly activated, creating a high risk for clot formation within these aneurysms. The primary goal of pharmacotherapy is to reduce this thrombotic risk.
Answer Rationale:
Key Point! The cornerstone of medical management for Kawasaki disease, especially when coronary artery abnormalities are present, is antiplatelet therapy with
aspirin. In the acute febrile phase, high-dose aspirin is used for its anti-inflammatory effect. Once the fever resolves, the dose is reduced to a low, antiplatelet dose (3-5 mg/kg/day) to
inhibit platelet aggregation and prevent thrombosis within the aneurysms. This is a long-term therapy that may continue for weeks, months, or even years depending on coronary artery findings. Therefore, administering it as prescribed and monitoring for side effects like bleeding (e.g., bruising, epistaxis, tarry stools) is the nurse's most direct and important intervention to prevent thrombotic complications.
Distractor Analysis:
Watch out for confusion! Option ② (Encourage increased fluid intake) is a supportive measure for any febrile child to prevent dehydration, but it does not directly address the pathophysiological mechanism of platelet aggregation and clot formation in coronary aneurysms.
Option ③ (Apply cool compresses) is a non-pharmacological comfort measure for fever, but it is not a primary intervention for preventing thrombosis. Antipyretics like acetaminophen are typically used alongside aspirin for fever management.
Option ④ (Restrict physical activity to complete bed rest) is incorrect. While strenuous activity may be restricted in children with giant aneurysms to reduce myocardial oxygen demand,
complete bed rest is not standard. Most children can engage in gentle, age-appropriate play. The focus is on medication to prevent clots, not immobilization.
Related Concepts: Kawasaki disease management is two-fold: 1)
Acute phase: High-dose aspirin + Intravenous Immunoglobulin (IVIG) to reduce inflammation and prevent aneurysm formation. 2)
Convalescent/subacute phase: Low-dose aspirin for antiplatelet effect. For children with giant aneurysms or a history of thrombosis, additional anticoagulants (e.g., warfarin, clopidogrel) may be added. Long-term cardiac follow-up with serial echocardiograms is mandatory.
Concept Summary
| Phase | Goal | Key Medication | Nursing Focus |
|---|
| Acute (Fever present) | Reduce inflammation, prevent aneurysm formation | High-dose Aspirin, IVIG | IVIG infusion monitoring, fever management, assess for IVIG adverse reactions |
| Convalescent (Fever resolved) | Prevent coronary thrombosis | Low-dose Aspirin (antiplatelet) | Administer as ordered, educate on bleeding precautions, ensure adherence |
| Long-term (With aneurysms) | Monitor cardiac status, prevent MI | Low-dose Aspirin ± other anticoagulants | Schedule follow-up echocardiograms, educate on signs of MI (chest pain, vomiting), activity guidance |
Side-by-Side Comparison!
| Feature | Kawasaki Disease | Acute Rheumatic Fever (ARF) |
|---|
| Primary Cause | Unknown (likely infectious trigger + immune response) | Autoimmune reaction to Group A Streptococcus (Strep throat) |
| Cardiac Involvement | Coronary artery aneurysms, vasculitis | Valvulitis (especially mitral valve), myocarditis |
| Key Diagnostic Finding | Echocardiogram for coronary arteries | Jones Criteria (e.g., carditis, polyarthritis, chorea) |
| Primary Drug for Prevention | Low-dose Aspirin (antiplatelet) | Penicillin (antibiotic to prevent recurrence) |
| Long-term Complication | Coronary thrombosis, Myocardial Infarction (MI) | Rheumatic Heart Disease (RHD), valvular stenosis/regurgitation |
Anatomy, Physiology & Pharmacology Points
Pathophysiology: KD causes panvasculitis (inflammation of all three layers of the artery wall). In the coronary arteries, this weakens the wall, leading to dilation (aneurysm). Turbulent blood flow in the aneurysm promotes platelet activation and adhesion, forming a thrombus that can occlude the vessel.
Pharmacology: Aspirin irreversibly inhibits the enzyme cyclooxygenase-1 (COX-1) in platelets, preventing the synthesis of thromboxane A2, a potent promoter of platelet aggregation. This antiplatelet effect lasts for the lifespan of the platelet (7-10 days).
Memory Tips
Acronym for KD Diagnostic Criteria (FEBRILE): Fever (≥5 days), Eyes (conjunctival injection), Bulbar conjunctivae (non-purulent), Rash (polymorphous), Internal oral changes (red lips/strawberry tongue), Lymphadenopathy (cervical, >1.5 cm), Extremities (red palms/soles, later peeling). Need 4 of these + fever.
Drug Phases: Think "HI-LO" for aspirin:
HIgh dose in acute phase for Inflammation,
LOw dose later to prevent cLOts.
High-Frequency NCLEX Topics
NCLEX loves to test the
priority intervention for preventing complications. For Kawasaki disease, the answer will almost always involve
aspirin administration and monitoring. Be ready to distinguish between the high-dose (anti-inflammatory) and low-dose (antiplatelet) indications. Also, know that IVIG is given in the acute phase to reduce inflammation and is a single infusion.
Watch Out for Question Variations!
* Instead of asking for the nursing intervention, a question might ask: "The nurse is teaching parents of a child with Kawasaki disease about long-term aspirin therapy. Which statement by a parent indicates understanding?" Correct response would relate to recognizing bleeding signs or not giving other NSAIDs.
* A question could present a child post-IVIG infusion and ask for priority assessment (e.g., for signs of fluid overload or anaphylaxis).
* A question might test knowledge of when to switch from high-dose to low-dose aspirin (typically after fever has been resolved for 48-72 hours).